Analytic validation of NeXT Dx™, a comprehensive genomic profiling assay-Reference-Cited by-同舟云学术

Analytic validation of NeXT Dx™, a comprehensive genomic profiling assay

Published:2023-08-30 Issue:1 Volume:14 Page:789-806
ISSN:1949-2553
Container-title:Oncotarget
language:en
Short-container-title:Oncotarget

Author:

Saldivar Juan-Sebastian¹²,Harris Jason¹²,Ayash Erin¹,Hong Manqing¹,Tandon Prateek¹,Sinha Saloni¹,Hebron Patricia Miranda¹,Houghton Erin E.¹,Thorne Kaleigh¹,Goodman Laurie J.¹,Li Conan¹,Marfatia Twinkal R.¹,Anderson Joshua¹,Morra Massimo¹,Lyle John¹,Bartha Gabor¹,Chen Richard¹

Affiliation:

1. Personalis, Inc., Fremont, CA 94555, USA

2. These authors contributed equally to this work

Publisher

Impact Journals, LLC

Subject

Oncology

Reference52 articles.

1. American Cancer Society. https://www.cancer.org/. Accessed Jan. 2023.

2. The current state of molecular testing in the treatment of patients with solid tumors, 2019;Marshall;CA Cancer J Clin,2019

3. Cancer Therapy Directed by Comprehensive Genomic Profiling: A Single Center Study;Anderson;Cancer Res,2016

4. Real-World Evidence In Support Of Precision Medicine: Clinico-Genomic Cancer Data As A Case Study;Abernethy;Health Aff (Millwood),2018

5. Genomic Profiling of Advanced Non-Small Cell Lung Cancer in Community Settings: Gaps and Opportunities;Goldberg;Clin Lung Cancer,2017

Cited by 2 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Analytical validation and clinical utilization of K-4CARE™: a comprehensive genomic profiling assay with personalized MRD detection;Frontiers in Molecular Biosciences;2024-02-09

2. Analytical validation and clinical utilization of K-4CARE^TM: a comprehensive genomic profiling assay with personalized MRD detection;2023-11-08